Canada-based TerrAscend, a biopharmaceutical and wellness company involved in the global cannabinoid market, has named Jeffrey J Puglisi as its new chief corporate officer, it was reported yesterday.
Puglisi will be responsible for the oversight and execution of the firm's US strategy.
Puglisi has been the executive vice president of Business Development and Corporate Affairs of the firm since December 2017. He has more than 30 years of experience in the capital markets and the securities industry. He co-founded Puglisi & Co. He also founded Puglisi Capital Partners LP.
ELIAS Animal Health names new chief revenue officer
enGene Holdings names new senior vice president, Urologic Oncology and Clinical Development
HealthTrackRx names new chief medical officer
PureTech announces launch of Seaport Therapeutics with USD100m Series A financing
Orsini Specialty Pharmacy names new CFO and EVP of Trade Relations and Account Management
Enable Biosciences names new chief financial officer
Cadenza Bio names new director
Ligand Pharmaceuticals launches Pelthos Therapeutics to drive ZELSUVMI commercialisation